VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $43,655,000 | -66.1% | 196,511 | -69.7% | 1.10% | -68.9% |
| Q1 2015 | $128,913,000 | -28.5% | 649,042 | -48.5% | 3.55% | -15.6% |
| Q4 2014 | $180,409,000 | -16.7% | 1,260,633 | -23.6% | 4.21% | -15.5% |
| Q3 2014 | $216,623,000 | +64.8% | 1,651,090 | +58.4% | 4.99% | +89.7% |
| Q2 2014 | $131,469,000 | +23.2% | 1,042,410 | +28.7% | 2.63% | +35.9% |
| Q1 2014 | $106,748,000 | +1363.1% | 809,743 | +1202.9% | 1.94% | +1216.3% |
| Q4 2013 | $7,296,000 | +12.2% | 62,148 | -0.3% | 0.15% | -6.4% |
| Q3 2013 | $6,501,000 | -73.9% | 62,308 | -78.4% | 0.16% | -69.6% |
| Q2 2013 | $24,884,000 | +193.2% | 289,077 | +155.5% | 0.52% | +84.0% |
| Q1 2013 | $8,487,000 | – | 113,134 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |